Chronic chorioamnionitis is the most common placental lesion in late preterm birth

Placenta

Volumn 34, Issue 8, 2013, Pages 681-689

  Lee, J ^a   Kim, J S ^b   Park, J W ^a   Park, C W ^a   Park, J S ^a   Jun, J K ^a   Yoon, B H ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Acute chorioamnionitis; Fetal vascular thrombo occlusive disease; Indicated preterm birth; Maternal vascular underperfusion; Spontaneous preterm birth; Villitis of unknown etiology

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CHORIOAMNIONITIS; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PLACENTA; PLACENTA PERFUSION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; TERM BIRTH;

EID: 84882449105     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2013.04.014     Document Type: Article

References (46)

1. Kent AL, Dahlstrom JE. Placental assessment: simple techniques to enhance best practice. Aust N Z J Obstet Gynaecol 2006;46:32-7.
2. Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta 2008;29(Suppl. A):S86-91.
3. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003;6:435-48.
4. Redline RW, Boyd T, Campbell V, Hyde S, Kaplan C, Khong TY, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:237-49.
5. Redline RW, Ariel I, Baergen RN, Desa DJ, Kraus FT, Roberts DJ, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:443-52.
6. Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation e a workshop report. Placenta 2005;26(Suppl. A):S114-7.
7. Mc Elrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A, Markenson G, et al. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol 2008;168:980-9.
8. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
9. Kelly R, Holzman C, Senagore P, Wang J, Tian Y, Rahbar MH, et al. Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol 2009;170:148-58.
10. Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006;19:773-82.
11. Gersell DJ, Phillips NJ, Beckerman K. Chronic chorioamnionitis: a clinico-pathologic study of 17 cases. Int J Gynecol Pathol 1991;10:217-29.
12. Jacques SM, Qureshi F. Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998;29:1457-61.
13. Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, et al. The frequency, clinical significance, and pathological features of chronic cho-rioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 2010;23:1000-11.
14. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006;118:1207-14.
15. Reddy UM, Ko CW, Raju TN, Willinger M. Delivery indications at late-preterm gestations and infant mortality rates in the United States. Pediatrics 2009;124:234-40.
16. Raju TN. Epidemiology of late preterm (near-term) births. Clin Perinatol 2006;33:751-63 [abstract vii].
17. Tomashek KM, Shapiro-Mendoza CK, Davidoff MJ, Petrini JR. Differences in mortality between late-preterm and term singleton infants in the United States, 1995-2002. J Pediatr 2007;151. 450-6.e1.
18. Talge NM, Holzman C, Wang J, Lucia V, Gardiner J, Breslau N. Late-preterm birth and its association with cognitive and socioemotional outcomes at 6 years of age. Pediatrics 2010;126:1124-31.
19. Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, La Jeunesse C, et al. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 2009;182:3919-27.
20. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007;38:1439-46.
21. Hong JS, Yi SW, Han YJ, Park YW, Nam CM, Kang HC, et al. Fetal growth and neonatal mortality in Korea. Paediatr Perinat Epidemiol 2007;21: 397-410.
22. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 1995;172:960-70.
23. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130-6.
24. Shim SS, Romero R, Hong JS, Park CW, Jun JK, Kim BI, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339-45.
25. Wenstrom KD, Andrews WW, Bowles NE, Towbin JA, Hauth JC, Goldenberg RL. Intrauterine viral infection at the time of second trimester genetic amnio-centesis. Obstet Gynecol 1998;92:420-4.
26. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
27. Tsekoura EA, Konstantinidou A, Papadopoulou S, Athanasiou S, Spanakis N, Kafetzis D, et al. Adenovirus genome in the placenta: association with histo-logical chorioamnionitis and preterm birth. J Med Virol 2010;82:1379-83.
28. Redline RW, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993;143:473-9.
29. Labarrere CA, Faulk WP. Maternal cellsinchorionic villi from placentaeofnormal and abnormal human pregnancies. Am J Reprod Immunol 1995;33:54-9.
30. Kim JS, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, et al. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histo-pathology 2008;52:457-64.
31. Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic cho-rioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLo S One 2011;6:e16806.
32. Karason K, Jernas M, Hagg DA, Svensson PA. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. BMC Car-diovasc Disord 2006;6:29.
33. Halloran PF, Fairchild RL. The puzzling role of CXCR3 and its ligands in organ allograft rejection. Am J Transplant 2008;8:1578-9.
34. Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, et al. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology 2011;53:596-603.
35. Chaichian S, Shoaee S, Saremi A, Pedar S, Firouzi F. Factors influencing success rate of leukocyte immunization and anti-paternal antibodies in spontaneous recurrent miscarriage. Am J Reprod Immunol 2007;57:169-76.
36. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 2010;87:67-73.
37. Bartel G, Walch K, Wahrmann M, Pils S, Kussel L, Polterauer S, et al. Prevalence and qualitative properties of circulating anti-human leukocyte antigen allo-antibodies after pregnancy: no association with unexplained recurrent miscarriage. Hum Immunol 2011;72:187-92.
38. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Over-expression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003;88:5555-63.
39. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
40. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12: 642-9.
41. Goldenberg RL, Andrews WW, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth Project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol 2006;195:792-6.
42. Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol 2005;193:1100-4.
43. Curtis BR, Reno C, Aster RH. Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases. Transfusion 2005;45:1308-13.
44. Gramatges MM, Fani P, Nadeau K, Pereira S, Jeng MR. Neonatal alloimmune thrombocytopenia and neutropenia associated with maternal human leukocyte antigen antibodies. Pediatr Blood Cancer 2009;53:97-9.
45. Starcevic M, Tomicic M, Malenica M, Zah-Matakovic V. Neonatal alloimmune thrombocytopenia caused by anti-HLA-A24 alloantibodies. Acta Paediatr 2010;99:630-2.
46. Altemani A, Gonzatti A, Metze K. How many paraffin blocks are necessary to detect villitis? Placenta 2003;24:116-7.